(Q44412032)

2 December 2017

title

Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features (English)

1 reference

2 December 2017

Pathological, Immunohistochemical and Cytogenetic Features of Papillary Renal Cell Carcinoma With Clear Cell Features (English)

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

25 August 2024

1 reference

1 reference

Tobias Klatte

1

1 reference

2 December 2017

Michela de Martino

5

1 reference

2 December 2017

Brian Shuch

6

1 reference

2 December 2017

Nazy Zomorodian

7

1 reference

2 December 2017

Jonathan W. Said

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074210

25 August 2024

David B. Seligson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074210

25 August 2024

P. Nagesh Rao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074210

25 August 2024

Fairooz F. Kabbinavar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074210

25 August 2024

Arie S. Belldegrun

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074210

25 August 2024

Allan J. Pantuck

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21074210

25 August 2024

language of work or name

English

0 references

publication date

12 November 2010

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0022534710045490?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

https://api.elsevier.com/content/article/PII:S0022534710045490?httpAccept=text/plain

25 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

http://www.jurology.com/doi/pdf/10.1016/j.juro.2010.09.013

25 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

25 August 2024

1 reference

2 December 2017

volume

185

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

30-35

1 reference

Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Papillary Renal Cell Carcinoma

25 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features

25 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p

25 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.

25 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors

25 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma

25 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Tissue microarrays for high-throughput molecular profiling of tumor specimens

25 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy

25 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity

25 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Alpha-methyl CoA racemase expression in renal cell carcinomas

25 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.

25 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Surveillance for renal cell carcinoma: why and how? When and how often?

25 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma

25 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.

25 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus

25 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma

25 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Sorafenib in advanced clear-cell renal-cell carcinoma

25 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

25 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Molecular biology of renal cortical tumors

25 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma

25 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors

25 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JURO.2010.09.013

25 August 2024

Identifiers

1 reference

2 December 2017

1 reference